Figures & data
Figure 1. Control group; (A) Endometrium, endometrial stromal cell (black arrow) (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained endothelial cell (yellow arrow); VEGFR-2 immunostained epithelial cell (blue arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).
![Figure 1. Control group; (A) Endometrium, endometrial stromal cell (black arrow) (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained endothelial cell (yellow arrow); VEGFR-2 immunostained epithelial cell (blue arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).](/cms/asset/bb19eeaf-d6aa-4286-87d5-4cba88e144ad/igye_a_2217295_f0001_c.jpg)
Figure 2. OHSS-placebo group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).
![Figure 2. OHSS-placebo group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).](/cms/asset/888bfe36-8c60-406e-b672-5da7b70703a6/igye_a_2217295_f0002_c.jpg)
Figure 3. Cabergoline group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).
![Figure 3. Cabergoline group; (A) Endometrium (hematoxylin-eosin × 200) (B) Endometrial stromal cell (black arrow); VEGFR-2 immunostained microvessel (red arrow) (× 200).](/cms/asset/839c0f70-064a-4bbc-8116-31bb12c15a0c/igye_a_2217295_f0003_c.jpg)
Table 1. A comparison of weight gain, ovarian volume, corpora lutea numbers, and numbers of endometrial VEGFR-2 stained cells between the groups.